Clinical outcomes and postoperative costs of robot-assisted radical prostatectomy in patients with prostate cancer in South Korea: Nationwide cohort study

IF 5.2 3区医学 Q1 SURGERY

Asian Journal of Surgery Pub Date : 2026-08-01 Epub Date: 2026-01-07 DOI:10.1016/j.asjsur.2025.12.165

Donghyun Lee, Jae Hun Shim, Yoonjong Bae, Se Young Choi

{"title":"Clinical outcomes and postoperative costs of robot-assisted radical prostatectomy in patients with prostate cancer in South Korea: Nationwide cohort study","authors":"Donghyun Lee, Jae Hun Shim, Yoonjong Bae, Se Young Choi","doi":"10.1016/j.asjsur.2025.12.165","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>No national comparison has been conducted between robot-assisted radical prostatectomy (RARP) and other surgical techniques for prostate cancer in South Korea. This study aimed to assess the clinical outcomes and postoperative costs of RARP relative to other radical prostatectomy methods.</div></div><div><h3>Methods</h3><div>We analyzed data from the National Health Insurance Service database for patients diagnosed with prostate cancer from 2004 to 2016. Patients who underwent RARP were matched with those who received other surgical treatments using propensity score matching. We then evaluated clinical outcomes and postoperative costs.</div></div><div><h3>Results</h3><div>Both groups comprised 12,108 patients, matched precisely by age, year of diagnosis, Charlson comorbidity index, hospital location, and hospital type. The RARP group experienced significantly lower transfusion rates (7.7 % vs. 39.2 %, p < 0.001), shorter hospital stays (8.96 days vs. 11.88 days, p < 0.001), and lower postoperative costs 1 year after surgery ($2775.40 vs. $2953.00, p = 0.004) compared to the non-RARP group.</div></div><div><h3>Conclusions</h3><div>RARP was associated with better clinical outcomes and lower postoperative costs than other surgical methods, largely due to reduced complications and improved management of incontinence and ADT use. Although multivariate analysis did not show significant superiority, RARP may still present a cost-effective approach for prostate cancer treatment by enhancing clinical outcomes and decreasing healthcare costs.</div></div>","PeriodicalId":55454,"journal":{"name":"Asian Journal of Surgery","volume":"49 8","pages":"Pages 4595-4601"},"PeriodicalIF":5.2000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1015958425036863","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

No national comparison has been conducted between robot-assisted radical prostatectomy (RARP) and other surgical techniques for prostate cancer in South Korea. This study aimed to assess the clinical outcomes and postoperative costs of RARP relative to other radical prostatectomy methods.

Methods

We analyzed data from the National Health Insurance Service database for patients diagnosed with prostate cancer from 2004 to 2016. Patients who underwent RARP were matched with those who received other surgical treatments using propensity score matching. We then evaluated clinical outcomes and postoperative costs.

Results

Both groups comprised 12,108 patients, matched precisely by age, year of diagnosis, Charlson comorbidity index, hospital location, and hospital type. The RARP group experienced significantly lower transfusion rates (7.7 % vs. 39.2 %, p < 0.001), shorter hospital stays (8.96 days vs. 11.88 days, p < 0.001), and lower postoperative costs 1 year after surgery ($2775.40 vs. $2953.00, p = 0.004) compared to the non-RARP group.

Conclusions

RARP was associated with better clinical outcomes and lower postoperative costs than other surgical methods, largely due to reduced complications and improved management of incontinence and ADT use. Although multivariate analysis did not show significant superiority, RARP may still present a cost-effective approach for prostate cancer treatment by enhancing clinical outcomes and decreasing healthcare costs.

查看原文本刊更多论文

韩国前列腺癌患者机器人辅助根治性前列腺切除术的临床结果和术后费用：全国队列研究

在韩国，尚未对机器人辅助根治性前列腺切除术（RARP）和其他前列腺癌手术技术进行全国性比较。本研究旨在评估RARP相对于其他根治性前列腺切除术的临床结果和术后成本。方法分析2004年至2016年国民健康保险服务数据库中诊断为前列腺癌的患者数据。采用倾向评分匹配法将接受RARP的患者与接受其他手术治疗的患者进行匹配。然后我们评估临床结果和术后费用。结果两组共有12108例患者，年龄、诊断年份、Charlson合并症指数、医院位置和医院类型精确匹配。与非RARP组相比，RARP组的输血率显著降低（7.7%对39.2%,p < 0.001），住院时间较短（8.96天对11.88天，p < 0.001），术后1年的费用较低（2775.40美元对2953.00美元，p = 0.004）。结论与其他手术方法相比，srarp具有更好的临床效果和更低的术后成本，主要原因是减少了并发症，改善了对尿失禁和ADT使用的管理。虽然多变量分析没有显示出显著的优势，但RARP可能仍然是一种具有成本效益的前列腺癌治疗方法，可以提高临床效果并降低医疗成本。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asian Journal of Surgery 医学-外科

CiteScore

3.60

自引率

31.40%

发文量

1589

审稿时长

33 days

期刊介绍： Asian Journal of Surgery, launched in 1978, is the official peer-reviewed open access journal of the Asian Surgical Association, the Taiwan Robotic Surgery Association, and the Taiwan Society of Coloproctology. The Journal is published monthly by Elsevier and is indexed in SCIE, Medline, ScienceDirect, Scopus, Embase, Current Contents, PubMed, Current Abstracts, BioEngineering Abstracts, SIIC Data Bases, CAB Abstracts, and CAB Health. ASJSUR has a growing reputation as an important medium for the dissemination of cutting-edge developments in surgery and its related disciplines in the Asia-Pacific region and beyond. Studies on state-of-the-art surgical innovations across the entire spectrum of clinical and experimental surgery are particularly welcome. The journal publishes original articles, review articles, and case reports that are of exceptional and unique importance. The journal publishes original articles, review articles, and case reports that are of exceptional and unique importance.